Godavari Biorefineries Limited · NSE:GODAVARIB
Godavari Biorefineries — Q2 FY26 Earnings Presentation
30 slides from Godavari Biorefineries's earnings presentation, Nov 13, 2025
Slide 1: Cover letter to stock exchanges: Investor Presentation
Dated: November 13, 2025 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB S
Slide 2: Investor Presentation Q2 & H1 FY26
www.godavaribiorefineries.com CREATING A BEAUTIFUL WORLD With Innovation at the Core, Unified in Growth, Sustainability & Inclusivity. Godavari Biorefineries Limited Investor Presentation Q2 & H1 FY26
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Godavari Biorefineries Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for an
Slide 4: Company Snapshot
Company Snapshot Business Performance R&D and Innovation Consumer Brand Q2 FY26 Highlights DME Technology Jivana Performance Consolidated Revolutionary Breakthrough in Climate Action: • Revenue growth of 35% YoY Godavari Biorefineries and ICT Mumbai launch • EBITDA losses contracted by Rs. 27.1 Crs
Slide 5: GBL Key Revenue, Growth Drivers & Business Updates
GBL Key Revenue, Growth Drivers & Business Updates In tune with Green Transitions in India & The World GBL’s Continued Focus on Bio-based Chemicals GBL’s Progress in Ethanol • Increase in Capacity and Capacity Utilisation • Increase in Revenue from Bio-Based Specialty Chemicals Business • Diversific
Slide 6: Q2 & H1 FY26 Business Performance
Q2 & H1 FY26 Business Performance
Slide 7: Q2 FY26 Performance Highlights (Y-o-Y Basis)
Q2 FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) Total Income EBITDA* PAT Rs. 434.3 Crs Rs. (4.4) Crs Rs. (41.6) Crs + 34.8% YoY Margin (1.0%) Margin (9.6%) EBITDA (Rs. Crs) PBT # (Rs. Crs) Finance Cost (Rs. Crs) -4.4 -30.2 -31.5 +27.1 -64.1 -8.0 +33.9 20.3 12.3 Q2 FY25 Q2 FY26 Q2 FY25 Q2
Slide 8: H1 FY26 Performance Highlights (Y-o-Y Basis)
H1 FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) Total Income EBITDA* PAT Rs. 968.2 Crs Rs. 2.1 Crs Rs. (57.6) Crs + 14.3% YoY Margin 0.2% Margin (5.9%) EBITDA (Rs. Crs) PBT # (Rs. Crs) Finance Cost (Rs. Crs) 2.1 -12.1 -52.5 39.9 -41.0 +43.1 -105.7 27.6 +53.2 H1 FY25 H1 FY26 H1 FY25 H1 FY
Slide 9: Q2 FY26 Performance Highlights: Revenue Mix
Q2 FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) Q2 FY25 Revenue-Mix * Q2 FY26 Revenue-Mix * 2% 2% 9% 24% 41% 52% 37% 34% Sugar & Cogen Bio-based chemicals Ethanol Unallocated Revenue from Bio-based chemicals & Ethanol increased to 58% in Q2 FY26 compared to 46% in Q2 FY25 8 *Some of the
Slide 10: H1 FY26 Performance Highlights: Revenue Mix
H1 FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) H1 FY25 Revenue-Mix * H1 FY26 Revenue-Mix * 1% 2% 20% 32% 37% 47% 32% 30% Sugar & Cogen Bio-based chemicals Ethanol Unallocated Revenue from Bio-based chemicals & Ethanol increased to 62% in H1FY26 compared to 52% in H1FY25 9 *Some of the b
Slide 11: Q2 FY26 Segmental Highlights-Bio-based Chemicals
Q2 FY26 Segmental Highlights-Bio-based Chemicals (Consolidated) Revenue (Rs. Crs) Q2 FY25 Q2 FY26 YoY Growth 120.0 147.1 23% Accelerating Growth Through Specialty Chemicals Revenue Break-up EBITDA (Rs. Crs) 37% +5.6 43% 15.0 57% 63% 9.4 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Non Specialty Chemical Specialt
Slide 12: H1 FY26 Segmental Highlights-Bio-based Chemicals
H1 FY26 Segmental Highlights-Bio-based Chemicals (Consolidated) Revenue (Rs. Crs) H1 FY25 H1 FY26 YoY Growth 266.0 288.3 8% Accelerating Growth Through Specialty Chemicals Revenue Break-up EBITDA (Rs. Crs) +9.5 46% 38% 27.6 62% 18.1 54% H1 FY25 H1 FY26 H1 FY25 H1 FY26 Non Specialty Chemical Specialt
Slide 13: Q2 FY26 Segmental Highlights- Ethanol
Q2 FY26 Segmental Highlights- Ethanol (Consolidated) Revenue (Rs. Crs) Q2 FY25 Q2 FY26 YoY Growth 29.3 101.2 246% Gaining Traction in Ethanol Business Revenue (Rs. Crs) EBITDA (Rs. Crs) +7.6 4.7 +71.9 101.2 -2.9 29.3 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 B-heavy molasses-based Ethanol back in play after p
Slide 14: H1 FY26 Segmental Highlights- Ethanol
H1 FY26 Segmental Highlights- Ethanol (Consolidated) Revenue (Rs. Crs) H1 FY25 H1 FY26 YoY Growth 165.7 306.6 85% Gaining Traction in Ethanol Business Revenue (Rs. Crs) EBITDA (Rs. Crs) +140.9 +9.2 306.6 17.8 165.7 8.6 H1 FY25 H1 FY26 H1 FY25 H1 FY26 B-heavy molasses-based Ethanol back in play after
Slide 15: Q2 FY26 Segmental Highlights- Sugar & Co-Generation
Q2 FY26 Segmental Highlights- Sugar & Co-Generation (Consolidated) Revenue (Rs. Crs) Q2 FY25 Q2 FY26 YoY Growth 165.5 174.5 5% Revenue Break-up (In %) EBITDA (Rs. Crs) 5% 4% 7% 3% 17% -23.2 21% -36.9 74% 69% +13.7 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Non Branded Sugar Branded Sugar Co-generation Others 1
Slide 16: H1 FY26 Segmental Highlights- Sugar & Co-Generation
H1 FY26 Segmental Highlights- Sugar & Co-Generation (Consolidated) Revenue (Rs. Crs) H1 FY25 H1 FY26 YoY Growth 400 352 (12%) Revenue Break-up (In %) EBITDA (Rs. Crs) 6% 2% 5% 7% 12% 18% -40.6 -65.6 70% 80% 18.0% +25.0 12.0% 7.0% 6.0% H1FY25 H1 FY26 H1 FY25 H1 FY26 Non Branded Sugar Branded Sugar Co
Slide 17: Consolidated Profit & Loss Statement – Q2 & H1 FY26
Consolidated Profit & Loss Statement – Q2 & H1 FY26 Particulars (in INR Cr) Q2 FY26 Q2 FY25 Y-o-Y Q1 FY26 Q-o-Q H1 FY26 H1 FY25 Y-o-Y Revenue from Operations 430.8 321.0 34.2% 533.2 (19.2%) 964.0 843.5 14.3% Other Income 3.5 1.1 0.7 4.3 3.9 Total Income 434.3 322.1 34.8% 534.0 (18.7%) 968.2 847.3 14
Slide 18: Consolidated Balance Sheet – H1 FY26
Consolidated Balance Sheet – H1 FY26 Particulars (in INR Cr) Sep 25 Mar 25 Particulars (in INR Cr) Sep 25 Mar 25 ASSETS EQUITY AND LIABILITIES EQUITY Non-current assets (i) Equity share capital 51.2 51.2 (a) Property, plant and equipment 841.6 861.3 (ii) Other equity 673.9 730.8 (b) Capital Work-in-
Slide 19: Consolidated Cash Flow Statement – H1 FY26
Consolidated Cash Flow Statement – H1 FY26 Particulars (in INR Cr) Sep 25 Sep 24 Cash Flow from Operating Activities Profit before Tax (79.2) (105.7) Adjustment for Non-Operating Items 50.0 62.5 Operating Profit before Working Capital Changes (29.2) (43.3) Changes in Working Capital 122.6 75.2 Cash
Slide 20: R&D and Innovations
R&D and Innovations =
Slide 21: Revolutionary Technology to Combat Climate Change
Revolutionary Technology to Combat Climate Change Converts Industrial CO2 Emissions directly into Dimethyl Ether (DME) • Sustainable Energy for the Future: DME’s versatility as a clean fuel and chemical carrier supports the global transition to renewables. • A Climate Game-Changer: Converts Groundbr
Slide 22: Road to Drug Discovery
Road to Drug Discovery Developing Innovative Therapies For Difficult-To-Treat Cancers • Oral First-In-Class novel chemical entity • Rich pipeline of anti-cancer drugs • Developing novel treatments for difficult- to-treat cancer types. Drug for triple negative breast cancer that accounts for 15% • LE
Slide 23: Road to Drug Discovery
Road to Drug Discovery Drug Discovery for Triple-Negative Breast Cancer (Promising preclinical efficacy in Tripple Negative Breast Cancer) Next Step In Process Preliminary Efficacy Mechanism of Trials: Out-licensing of Pre-Clinical Safety Action Preparation of Molecule Trials Trials Application Ther
Slide 24: Consumer Brand
Consumer Brand Godavari Biorefineries Ltd
Slide 25: Jivana - The Pure, Chemical Free, Sustainable Food Brand
Jivana - The Pure, Chemical Free, Sustainable Food Brand Clean & Healthy products for the aware consumer. High Growth Trajectory 01 • Revenue growth from Rs. 28 Cr in FY22 to Rs. 108 Crs in FY25 with a CAGR of 56%. • H1FY26 witnessed growth of 25% with Rs. 66 Crs revenue. Deeper Brand Penetration/Ge
Slide 26: Company Overview
Company Overview
Slide 27: Integrated Bio-refinery across value chain: Sugar, Ethanol, Bio-Chemicals, Power & Others
Integrated Bio-refinery across value chain: Sugar, Ethanol, Bio-Chemicals, Power & Others… Planned Products GRAIN BASED ETHANOL SPECIALTY CHEMICALS Current Products 26
Slide 28: Board of Directors
Board of Directors Promoter has played a significant role in the development and growth of the company... Shri Samir Shantilal Somaiya (Chairman & Managing Director) • Conferred with the ‘ Knight of the Order of the Star of Italy’ • Conferred with ‘Lala Shriram National Award for Leadership in the C
Slide 29: Board of Directors
Board of Directors Nandan Mehta Hemant Luthra (Independent Director) (Independent Director) • B.Sc. (Chem) St. Xavier’s College, Mumbai , MBA Nyenrode University, The • Bachelors’ degree of technology in Mechanical Engineering from IIT, Delhi Netherlands. • Founder Chairman of Mahindra CIE, Mahindra
Slide 30: Thank You
Thank You Godavari Biorefineries Ltd CIN: L67120MH1956PLC009707 Name – Mr. Ashish Sinha Title – AGM- IR & Finance Email – investorrelations@somaiya.com Ms. Prachi Ambre Mr. Irfan Raeen +91 83559 85370 +91 97737 78669 Prachi.ambre@in.mpms.mufg.com irfan.raeen@in.mpms.mufg.com
Godavari Biorefineries — Q2 FY26 Earnings Presentation on 6ix